Trial Profile
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Donepezil Hydrochloride (E2020) in Patients With Dementia Associated With Cerebrovascular Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Donepezil (Primary)
- Indications Dementia
- Focus Therapeutic Use
- Sponsors Eisai Co Ltd
- 21 Jan 2019 Status changed from active, no longer recruiting to completed.
- 25 May 2018 Planned End Date changed from 1 Sep 2018 to 1 Jan 2019.
- 05 Feb 2018 Planned End Date changed from 1 Feb 2018 to 1 Sep 2018.